GeneDx Quarterly Balance Sheet
NASDAQ: WGSHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GeneDx financial position
As of Jun 30, 2026, GeneDx reported total assets of $481.5 million, up 3.8% from a year earlier against total liabilities of $237.3 million. Shareholders' equity stood at $244.2 million, or 50.7% of assets. The company held $60.3 million in cash and equivalents against $96.8 million of debt, a net debt position of $36.5 million.
The current ratio (current assets divided by current liabilities) was 3.30, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.40.
Summary generated from market data by MetaCap's automated system. Methodology
GeneDx balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 60.32M | 93.92M | 105.00M | 95.97M | 74.12M | 99.70M | 85.21M | 57.89M | 56.08M | 83.67M | 99.68M | 87.39M |
| Short-Term Investments | 72.23M | 76.76M | 66.28M | 59.11M | 60.44M | 59.46M | 55.97M | 58.57M | 50.78M | 29.24M | 30.47M | 26.91M |
| Receivables | 83.61M | 76.93M | 74.37M | 60.94M | 48.03M | 45.98M | 37.63M | — | — | — | — | — |
| Inventory | 17.82M | 12.24M | 13.95M | 10.57M | 11.93M | 12.66M | 10.65M | 10.77M | 10.32M | 11.62M | 8.78M | 9.35M |
| Total Current Assets | 246.36M | 270.63M | 268.29M | 237.58M | 204.84M | 225.82M | 197.97M | 186.01M | 162.17M | 163.42M | 182.34M | 171.81M |
| Property, Plant & Equipment | 54.32M | 50.13M | 45.69M | 42.42M | 40.12M | 36.38M | 32.89M | 31.45M | 31.34M | 31.30M | 32.48M | 35.75M |
| Goodwill | 1.64M | 1.64M | 13.52M | 12.80M | 12.93M | — | 0 | — | — | — | — | — |
| Intangible Assets | 141.35M | 144.97M | 168.48M | 172.59M | 176.69M | 155.09M | 158.60M | 162.11M | 165.61M | 169.12M | 172.63M | 176.13M |
| Total Assets | 481.49M | 506.30M | 523.71M | 493.90M | 463.86M | 446.43M | 419.38M | 408.84M | 389.10M | 394.53M | 418.76M | 417.29M |
| Accounts Payable | 5.15M | 11.17M | 2.46M | 2.63M | 3.52M | 15.86M | 7.95M | 9.02M | 8.13M | 9.48M | 10.24M | 15.37M |
| Short-Term Debt | 0 | 0 | 4.54M | 1.23M | 1.22M | 1.22M | 1.21M | 1.21M | 1.10M | 798.00K | 497.00K | 198.00K |
| Total Current Liabilities | 74.63M | 87.64M | 108.91M | 87.62M | 71.41M | 69.54M | 54.82M | 77.34M | 68.27M | 50.73M | 58.82M | 68.37M |
| Long-Term Debt | 96.84M | 96.73M | 48.18M | 51.58M | 51.68M | 51.79M | 51.91M | 52.03M | 52.16M | 52.29M | 52.69M | 6.05M |
| Total Liabilities | 237.26M | 252.18M | 215.53M | 201.64M | 186.73M | 189.03M | 174.13M | 204.34M | 195.06M | 187.31M | 190.74M | 163.03M |
| Shareholders' Equity | 244.22M | 254.12M | 308.18M | 292.26M | 277.13M | 257.40M | 245.25M | 204.50M | 194.04M | 207.22M | 228.02M | 254.26M |
| Retained Earnings | -1.45B | -1.44B | -1.37B | -1.36B | -1.35B | -1.36B | -1.35B | -1.36B | -1.35B | -1.32B | -1.30B | -1.27B |
| Total Debt | 96.84M | 96.73M | 52.72M | 52.81M | 52.91M | 53.01M | 53.12M | 53.24M | 53.26M | 53.09M | 53.19M | 6.25M |
| Net Cash (Debt) | 35.71M | 73.95M | 118.56M | 102.27M | 81.65M | 106.15M | 88.06M | 63.22M | 53.60M | 59.82M | 76.96M | 108.05M |
| Shares Outstanding | 29.80M | 29.67M | 29.25M | 28.89M | 28.71M | 28.53M | 28.02M | 27.43M | 26.93M | 26.12M | 25.98M | 25.88M |
This table shows 12 quarterly periods of GeneDx's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow WGS's reporting calendar. What is a balance sheet?